Top of the morning to you. Gray skies are hovering over the Pharmalot corporate campus this morning, where we are hustling the short people off to the school house for some learning and quaffing our usual cup of stimulation - our flavor today is Mocha Fudge Nut. Please join us. While you do, here are some tidbits from around your universe. We hope your day is productive and rewarding. Meanwhile, let us know of anything interesting or unusual. Have a great one...
Study Reveals New Target For Antidepressants (Reuters)
Teva MS Pill Reduces Relapses Less Most Injectables (Bloomberg News)
Glaxo Moving More Jobs To Scotland (Scotland Herald)
FDA Approves Merck Skin Cancer Drug (Reuters)
Biogen MS Pill Shows Promise In Study (Associated Press)
UK Docs May Consider Cost When Prescribing Off-Label: Proposal (Pharma Times)
Man Sentenced To 31 Years For Kidnapping Pharma Delivery Driver (The Republic)
Pfizer's Dimebon Fails In Huntington's Study (Associated Press)
Exelis Hires Goldman Sachs To Field Takeover Offers (Bloomberg News)
2 Comments
"And the rest of the day to you," Mr Silverman!
The move by Witty is consistent with his view towards reestablishing GSK as a "UK centric" company. Look for more jobs to come back to the UK from other parts of the world, including the United States, from what my sources tell me.